SCYX 7158: Clinical Trials

2 trials of SCYX 7158, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow SCYX 7158: new trials by email Literature Review of SCYX 7158 trials Research Report on SCYX 7158

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
Acoziborole - Trypanosomiasis, African, Gambiense Trypanosomiasis
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases2082016-10-112025-09-17
Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
SCYX-7158, Placebo - Trypanosomiasis, Trypanosomiasis, African
Phase 1CompletedDrugs for Neglected Diseases1362012-02-012015-09-18

Conditions studied

Trypanosomiasis, African (2)  ·  Neglected Diseases (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Trypanosomiasis (1)

Sponsors

Drugs for Neglected Diseases (2)

Countries

Democratic Republic of the Congo (1)  ·  France (1)  ·  Guinea (1)

Top investigators

Antoine Tarral, MD (1)  ·  Victor Kande Betu Kumeso, Dr (1)

Results publications

PMID 36460027, PMID 36763327